Finance
Amedisys announces pricing of $67.7M follow-on offering
Published in Physician Business Week, October 12th, 2004
The company increased the size of the offering by 460,000 shares from the previously announced offering size of 2.0 million shares. For a period of 30 days following the offering, the underwriters of the offering have an option to purchase an additional 300,000 shares of Amedisys, Inc., common stock at the offering price to cover over-allotments.
If exercised in full, the over-allotment will include 150,000 shares offered by existing stockholders, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- CryoLife, Inc.
Biosurgical device company presented results of SynerGraft arteriovenous device - RITA Medical Systems, Inc.
CIGNA HealthCare will cover radiofrequency ablation liver treatment - Aachen University Hospital, Germany
Cochlear implantation in the elderly enhances quality of life - Aichi Cancer Center
Polymorphism increases disease risk in some premenopausal Japanese women - Awards
Hospitalists receive 2004 John M. Eisenberg Patient Safety and Quality Awards - Brigham & Women's Hospital
HIV/AIDS healthcare infrastructure helps decrease risk of drug resistance - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
